News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Aratana Therapeutics (PETX) To Present At Two Upcoming Investor Conferences


3/7/2014 6:29:03 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

KANSAS CITY, Kan., March 6, 2014 /PRNewswire/ -- Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing or acquisition, development and commercialization of innovative biopharmaceutical products for cats, dogs and other companion animals, today announced that it will present at two upcoming investor events. Aratana will present at the Barclays Global Healthcare Conference, to be held March 11-13, 2014, in Miami, Florida, and also the Jefferies Animal Health Day, to be held March 27, 2014, in New York City.

Steven St. Peter, M.D., President and Chief Executive Officer, will provide an overview of the Company's business during his live presentations and will be available to participate in one-on-one meetings with investors who are registered to attend the conferences.

Event:


Barclays Global Healthcare Conference

Date:


Tuesday, March 11, 2014

Time:


10:15 am (Eastern Time)

Location:


Loews Miami Hotel, Miami Beach, FL

Event:


Jefferies Animal Health Day

Date:


Thursday, March 27, 2014

Time:


10:10 am (Eastern Time)

Location:


New York, NY

The presentation at the Barclays Global Healthcare Conference will be webcast live and remain available for 30 days following the presentation. To access the webcast, please visit the investor relations section of the Aratana website at aratana.investorroom.com.

About Aratana Therapeutics
Aratana Therapeutics is a pet therapeutics company focused on the licensing or acquisition, development and commercialization of innovative biopharmaceutical products for cats, dogs and other companion animals. Aratana believes that it can leverage the investment in the human biopharmaceutical industry to bring therapeutics to pets in a capital and time efficient manner. Aratana believes the development and commercialization of these therapeutics will permit veterinarians and pet owners to manage pets' medical needs safely and effectively, resulting in longer and improved quality of life for pets. For more information, please visit www.aratana.com.

Contacts:
Tiberend Strategic Advisors, Inc.

Joshua Drumm, Ph.D.
jdrumm@tiberend.com; (212) 375-2664

Andrew Mielach
amielach@tiberend.com; (212) 375-2694

SOURCE Aratana Therapeutics, Inc.



Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES